Source link : https://www.newshealth.biz/health-news/fda-expands-approval-of-esketamine-for-depression/
The FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an inadequate response to at least two oral antidepressants, maker Johnson & Johnson announced on Tuesday. Used under the supervision of a healthcare provider, esketamine was first approved in 2019 for use alongside an oral antidepressant for treatment-resistant depression, […]
Author : News Health
Publish date : 2025-01-21 20:33:58
Copyright for syndicated content belongs to the linked Source.
Categories